Health Canada
- Status: approved
🇨🇦 MDD diagnosis and Fluoxetine treatment in Canada
MDD diagnosis and Fluoxetine treatment (MDD diagnosis and Fluoxetine treatment) regulatory status in Canada.
Marketing authorisation
MDD diagnosis and Fluoxetine treatment in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Canada
Frequently asked questions
Is MDD diagnosis and Fluoxetine treatment approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for MDD diagnosis and Fluoxetine treatment in Canada?
University of Pennsylvania is the originator. The local marketing authorisation holder may differ — check the official source linked above.